LigaChem Biosciences Inc. Logo

LigaChem Biosciences Inc.

Advancing a next-gen ADC platform to develop innovative medicines for unmet needs.

141080 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전광역시 유성구 국제과학10로 10 (주)레고켐 바이오사이언스, 대전광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

LigaChem Biosciences Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative medicines for unmet medical needs. The company specializes in research and development focused on Antibody-Drug Conjugates (ADCs), immuno-oncology, and synthetic small molecule drugs. Its core strength is a proprietary, next-generation ADC platform technology engineered to overcome the limitations of conventional ADCs. LigaChem Biosciences accelerates global drug development through an open innovation model, actively pursuing co-research, co-development, and licensing agreements with global partners.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for LigaChem Biosciences Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-09 00:00
Regulatory News Service
투자판단관련주요경영사항 (신규 항체-약물 결합체(ADC) 연구개발을 위한 공동연구 및 항체 기술도입 계약 체결)
Korean 10.5 KB

Automate Your Workflow. Get a real-time feed of all LigaChem Biosciences Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for LigaChem Biosciences Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan 4978
Develops RNA aptamer therapeutics for ophthalmology, pain, fibrosis, and other unmet medical needs.
Japan 4591
Rise Consulting Group, Inc. Logo
Execution-focused consulting for strategy and digital transformation, specializing in JP-CN markets.
Japan 9168
ROQUEFORT THERAPEUTICS PLC Logo
Developing first-in-class, pre-clinical medicines for hard-to-treat cancers.
United Kingdom ROQ
ROSS GROUP PLC Logo
A holding company in liquidation, formerly providing supply chain management & technology solutions.
United Kingdom RGP
ROXX, Inc. Logo
HR tech platform connecting non-desk job seekers with full-time roles using AI and vetting tools.
Japan 241A
SAFTEC CO.,LTD. Logo
Rents and sells safety equipment for construction, from basic supplies to AI/IoT solutions.
Japan 7464
Saniona Logo
Develops ion channel medicines for rare neurological diseases and epilepsy.
Denmark SANION
SBI Leasing Services Co.,Ltd. Logo
Structures Japanese Operating Leases for aircraft & ships for corporate investors.
Japan 5834
Sensorion Logo
Developing gene therapies and small molecules to restore, treat, and prevent hearing loss.
France ALSEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.